Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
49.17 Down 2.00(3.91%) Jul 31, 4:00PM EDT
|After Hours : 49.17 0.00 (0.00%) Jul 31, 5:04PM EDT
Prev Close:51.17
Open:50.42
Bid:N/A
Ask:55.25 x 100
1y Target Est:N/A
Beta:0.95
Next Earnings Date: 4-Aug-14LGND Earnings announcement
Day's Range:48.92 - 51.67
52wk Range:36.82 - 80.42
Volume:273,638
Avg Vol (3m):301,950
Market Cap:1.02B
P/E (ttm):84.34
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 3.91%1.02B
LLYDown 2.49%65.44B
MRKDown 2.31%166.85B
RHHBYDown 1.36%246.82B

Key Statistics

Forward P/E (1 yr):20.32
P/S (ttm):19.90
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.44
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback